Loading
Losing hair is one of the most distressing side-effects of chemotherapy and can often be prevented with a cooling cap. Make it routinely available and paid for.
Scalp cooling reduces chemotherapy-induced alopecia in randomised trials and is cleared by regulators, yet availability depends on charity, geography and unit culture. The proposal is payer coverage and unit-level capacity for scalp cooling for all patients receiving alopecia-inducing regimens who want it, plus trials of adjunctive topical agents, with hair preservation and body-image outcomes measured in registries.
Shares Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials, Toxicity and quality of life are undervalued.
Shares Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials, Toxicity and quality of life are undervalued.
Shares Wigs, cranial prostheses and head coverings, Minoxidil for persistent chemotherapy- and endocrine-therapy hair loss, Scalp cooling (cold caps: DigniCap, Paxman), Toxicity and quality of life are undervalued.
Shares Minoxidil for persistent chemotherapy- and endocrine-therapy hair loss, Scalp cooling (cold caps: DigniCap, Paxman), Toxicity and quality of life are undervalued.
Shares Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials, Toxicity and quality of life are undervalued.
Shares Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials, Toxicity and quality of life are undervalued.
Shares Minoxidil for persistent chemotherapy- and endocrine-therapy hair loss, Scalp cooling (cold caps: DigniCap, Paxman), Toxicity and quality of life are undervalued.
Shares Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials, Toxicity and quality of life are undervalued.